Veedol Corporation Limited (NSE:VEEDOL)
India
· Delayed Price · Currency is INR 1,321.40
+20.90 (1.61%)
Mar 10, 2026, 11:00 AM IST
Veedol Corporation Revenue
Veedol Corporation had revenue of 5.38B INR in the quarter ending December 31, 2025, with 11.47% growth. This brings the company's revenue in the last twelve months to 20.94B, up 8.79% year-over-year. In the fiscal year ending March 31, 2025, Veedol Corporation had annual revenue of 19.70B with 1.96% growth.
Revenue (ttm)
20.94B
Revenue Growth
+8.79%
P/S Ratio
1.06
Revenue / Employee
43.34M
Employees
483
Market Cap
22.10B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 19.70B | 378.80M | 1.96% |
| Mar 31, 2024 | 19.33B | 788.10M | 4.25% |
| Mar 31, 2023 | 18.54B | 3.18B | 20.71% |
| Mar 31, 2022 | 15.36B | 2.77B | 22.03% |
| Mar 31, 2021 | 12.58B | -580.90M | -4.41% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NOCIL | 13.12B |
| Savita Oil Technologies | 41.44B |
| Fineotex Chemical | 5.78B |
| Sirca Paints India | 4.59B |
| Rossari Biotech | 22.91B |
| Tatva Chintan Pharma Chem | 4.80B |
| S H Kelkar and Company | 22.82B |
| Jubilant Agri and Consumer Products | 18.04B |